Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential.

Area of Science:

• Regenerative Medicine
• Stem Cell Therapy
• Bioethics

Background:

• Regenerative medicine holds significant promise for tissue repair and regeneration.
• Growing concerns exist regarding unregulated stem cell therapies and premature regulatory approvals lacking sufficient evidence.
• The InterAcademy Partnership (IAP) initiative addressed these challenges to foster responsible innovation.

Purpose of the Study:

• To convene global experts to identify opportunities and challenges in regenerative medicine, focusing on stem cells.
• To develop consensus-based recommendations for supporting research and innovation while protecting patients.
• To outline actionable options for sharing best practices and enhancing global collaboration.

Main Methods:

• Convening a diverse group of international experts.
• Facilitating inclusive discussions to achieve consensus outputs.
• Addressing key issues including ethical assessment, research standards, regulatory pathways, and public engagement.

Main Results:

• Identification of critical challenges posed by unregulated clinics and insufficient regulatory oversight.
• Development of strategies for ethical assessment, robust pre-clinical and clinical research, and appropriate regulatory authorization.
• Emphasis on the importance of patient engagement and public dialogue.

Conclusions:

• A global consensus was reached on the need for a balanced approach to regenerative medicine.
• The InterAcademy Partnership (IAP) proposed actionable steps for responsible advancement of the field.
• Collaboration among scientists, regulators, policymakers, and the public is crucial for realizing the potential of regenerative medicine safely and effectively.